Medical Device Quality Control and Regulation Services

Regulation and quality control of medical devices are central elements in ensuring safety, performance, traceability, and continuity of operation in highly regulated markets.

Unlike other products, medical devices are subject to rigorous technical requirements, continuous monitoring, and clear responsibilities throughout their lifecycle.

ELS Group acts as a strategic technical partner in regulatory and quality management services for medical devices, supporting manufacturers, distributors, and marketing authorization holders from the development phase to post-marketing, with integrated operations in Europe and Latin America.

With a presence in 11 countries, specialized local teams, and direct experience with regulatory authorities and notified bodies, ELS Group structures regulatory and quality solutions that enable predictable operation, reduced risk, and the sustainability of international operations.

ELS Group's comprehensive scope of Medical Device Regulation and Quality Control.

ELS Group’s expertise in medical device regulation and quality control covers the entire product lifecycle, from initial regulatory compliance to post-market, including certifications, audits, and ongoing surveillance.

Our work includes the following integrated and customized services:

  • Risk Classification Analysis of medical devices according to the local regulatory body.
  • Preparation of regulatory feasibility reports for the registration of medical devices.
  • Conformity assessment and verification of compliance with regulatory requirements.
  • Gap Analysis of the technical documentation
  • Strategic regulatory support
  • Medical Device Registration, including preparation, review, and submission of the technical dossier.
  • Medical Device Notification, including preparation and submission of the technical dossier.
  • Renewal of registration for medical devices
  • Post-registration changes
  • Cancellation of registration of medical devices
  • Transfer of ownership of medical device registration
  • Drafting responses to health and safety notifications and violations.
  • Administrative appeal at the first instance level for the regularization of medical devices.
  • Preparation of MDR dossier for medical devices.
  • Updating MDD dossiers to MDR in the European Union
  • EUDAMED Registry
  • Authorised European Representative (EUAR / EU REP)
  • Person Responsible for Regulatory Compliance (PRRC)
  • UK Responsible Person (UK REP)
  • Responsible Person from Switzerland (CH REP)
  • UK Conformity Assessment Certification (UKCA)
  • Regulatory support at MHRA
  • ISO 13485 Certification
  • ISO 14971 Certification
  • Good Manufacturing Practices Certification for Medical Devices
  • Certification of Good Distribution Practices for Medical Devices
  • CE certification for medical devices
  • MDSAP certification and MDSAP audits
  • Preparation for audits by notified bodies
  • Compliance audits
  • INMETRO Certification (IEC 60601)
  • ANATEL Certification
  • Medical Device Code (CDM) Assignment
  • Unique Device Identification (UDI)
  • Verification of labeling requirements
  • Post-marketing surveillance
  • Post-marketing monitoring
  • Post-market studies
  • Post-market performance monitoring (PCPM)
  • Post-marketing clinical follow-up (PCCF)
  • Clinical Assessment Report (CER)
  • Clinical Evaluation Report for Medical Devices
  • Periodic Safety Report (PSR)
  • Handling complaints and recalls
  • Safety and performance assurance for in vitro diagnostic medical devices (GSPR)
  • Verification and validation of medical devices
  • Preclinical studies and clinical studies
  • Legal representative
  • Technical representation
  • Post-registration surveillance
  • Import and export of medical devices
  • Free Sale Certificate

By integrating regulation and quality control of medical devices into a single strategy, the ELS Group enables companies to operate with greater regulatory predictability, technical safety, and continuous compliance across multiple markets.

More than just executing processes, the group acts as a strategic partner, supporting critical decisions that impact patient safety, product performance, and the sustainability of regulatory operations over time.

Strategic consulting for the pharmaceutical and regulatory industry.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.

I want to speak to a Specialist

Frequently asked questions about regulation and quality control of medical devices.

It is the set of regulatory, technical, and quality activities that ensure medical devices meet the legal, safety, and performance requirements demanded by health authorities.

This includes risk classification, registrations, certifications, clinical evaluation, post-marketing surveillance, and maintaining compliance throughout the product lifecycle.

From the initial stages of device development, the regulatory framework must be defined before registration, but it remains necessary during commercialization, audits, post-registration changes, expansions into new markets, and post-market surveillance activities.

Risk classification determines the level of regulatory requirements applicable to the device. An incorrect classification can lead to rework, delays, additional requirements, or even rejection of the regulatory process.

Therefore, risk classification analysis is a critical step in the regulatory strategy.

ISO 13485 establishes the requirements for quality management systems applicable to medical devices.

It is an essential pillar for certifications, audits, and regulatory compliance in various markets, and is treated by the ELS Group as an integral part of its regulatory strategy, not just a documentary requirement.

ELS Group operates internationally, with a presence in 11 countries, offering regulatory and quality support in Europe and Latin America.

The company has specialized local teams that work in an integrated manner with the main regulatory authorities in each region, allowing it to align global strategies with the specific regulatory requirements of each market.